136 related articles for article (PubMed ID: 23154492)
1. The pathology of ocular cancer.
Eagle RC
Eye (Lond); 2013 Feb; 27(2):128-36. PubMed ID: 23154492
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome analysis reveals molecularly distinct subtypes in retinoblastoma.
Zeng Q; Wang S; Chen L; Wang J
Sci Rep; 2023 Sep; 13(1):16475. PubMed ID: 37777551
[TBL] [Abstract][Full Text] [Related]
3. Retinoblastoma: An overview.
Pandey AN
Saudi J Ophthalmol; 2014 Oct; 28(4):310-5. PubMed ID: 25473349
[TBL] [Abstract][Full Text] [Related]
4. Ocular melanoma: an overview of the current status.
Jovanovic P; Mihajlovic M; Djordjevic-Jocic J; Vlajkovic S; Cekic S; Stefanovic V
Int J Clin Exp Pathol; 2013; 6(7):1230-44. PubMed ID: 23826405
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathology of uveal melanoma.
Coupland SE; Lake SL; Zeschnigk M; Damato BE
Eye (Lond); 2013 Feb; 27(2):230-42. PubMed ID: 23222563
[TBL] [Abstract][Full Text] [Related]
6. Uveal melanoma cells utilize a novel route for transendothelial migration.
Onken MD; Li J; Cooper JA
PLoS One; 2014; 9(12):e115472. PubMed ID: 25506912
[TBL] [Abstract][Full Text] [Related]
7. Prognostic parameters in uveal melanoma and their association with BAP1 expression.
van Essen TH; van Pelt SI; Versluis M; Bronkhorst IH; van Duinen SG; Marinkovic M; Kroes WG; Ruivenkamp CA; Shukla S; de Klein A; Kiliç E; Harbour JW; Luyten GP; van der Velden PA; Verdijk RM; Jager MJ
Br J Ophthalmol; 2014 Dec; 98(12):1738-43. PubMed ID: 25147369
[TBL] [Abstract][Full Text] [Related]
8. Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives.
Buder K; Gesierich A; Gelbrich G; Goebeler M
Cancer Med; 2013 Oct; 2(5):674-86. PubMed ID: 24403233
[TBL] [Abstract][Full Text] [Related]
9. Current and emerging treatment options for uveal melanoma.
Pereira PR; Odashiro AN; Lim LA; Miyamoto C; Blanco PL; Odashiro M; Maloney S; De Souza DF; Burnier MN
Clin Ophthalmol; 2013; 7():1669-82. PubMed ID: 24003303
[TBL] [Abstract][Full Text] [Related]
10. Tumours associated with BAP1 mutations.
Murali R; Wiesner T; Scolyer RA
Pathology; 2013 Feb; 45(2):116-26. PubMed ID: 23277170
[TBL] [Abstract][Full Text] [Related]
11. Incidence and prevalence of eye cancer.
Kleinstein RN; Lehman HF
Am J Optom Physiol Opt; 1977 Jan; 54(1):49-51. PubMed ID: 860751
[TBL] [Abstract][Full Text] [Related]
12. Retinoblastoma, the visible CNS tumor: A review.
Dimaras H; Corson TW
J Neurosci Res; 2019 Jan; 97(1):29-44. PubMed ID: 29314142
[TBL] [Abstract][Full Text] [Related]
13. Retinoblastoma.
Rao R; Honavar SG
Indian J Pediatr; 2017 Dec; 84(12):937-944. PubMed ID: 28620731
[TBL] [Abstract][Full Text] [Related]
14. Retinoblastoma with MYCN Amplification Diagnosed from Cell-Free DNA in the Aqueous Humor.
Joseph S; Pike S; Peng CC; Brown B; Xu L; Berry JL; Chévez-Barrios P; Hubbard GB; Grossniklaus HE
Ocul Oncol Pathol; 2024 Apr; 10(1):15-24. PubMed ID: 38751495
[TBL] [Abstract][Full Text] [Related]
15. Investigation of PACAP38 and PAC1 Receptor Expression in Human Retinoblastoma and the Effect of PACAP38 Administration on Human Y-79 Retinoblastoma Cells.
Tóth D; Fábián E; Szabó E; Patkó E; Vicena V; Váczy A; Atlasz T; Tornóczky T; Reglődi D
Life (Basel); 2024 Jan; 14(2):. PubMed ID: 38398694
[TBL] [Abstract][Full Text] [Related]
16. Analyzing Cancer Incidence Trends in Oman From 1996 to 2019: A Comprehensive Study of the National Cancer Annual Reports.
Al-Sayegh H; Al-Zadjali S; Al-Moundhri M
JCO Glob Oncol; 2024 Jan; 10():e2300337. PubMed ID: 38271648
[TBL] [Abstract][Full Text] [Related]
17. Vitreous Seed Classification and Regression Patterns in Eyes With Retinoblastoma.
Rishi P; Attiku Y; Manchegowda PT; Agarwal A; Sharma M
J Vitreoretin Dis; 2021; 5(2):121-129. PubMed ID: 37009089
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicles as a new horizon in the diagnosis and treatment of inflammatory eye diseases: A narrative review of the literature.
Habibi A; Zarei-Behjani Z; Falamarzi K; Malekpour M; Ebrahimi F; Soleimani M; Nejabat M; Khosravi A; Moayedfard Z; Pakbaz S; Dehdari Ebrahimi N; Azarpira N
Front Immunol; 2023; 14():1097456. PubMed ID: 36969177
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
